Masato Okada

1.9k citations
47 papers · 880 indexed · h-index 14
Topics
Rheumatoid Arthritis Research and Therapies (17 papers)Systemic Lupus Erythematosus Research (15 papers)Spondyloarthritis Studies and Treatments (8 papers)
Partner nations
JapanUnited StatesSweden

In The Last Decade

Masato Okada

44 papers receiving 860 citations

Peers

Masato Okada
Comparison fields: 5 of 70
  • Rheumatology 503
  • Immunology 457
  • Radiology, Nuclear Medicine and Imaging 209
  • Molecular Biology 174
  • Hematology 91
Replace Patrick Danoy with:
Patrick Danoy Australia
Amy E. Wandstrat United States
Hector L. Franco United States
Boli Fan Canada
Heidy Zinger Israel
Evan Der United States
Cosmin Tegla United States
Fehim Esen Türkiye
Pedro Oyuela United States
Amy Pace United States
Masato Okada relative to Patrick Danoy Australia Patrick Danoy's profile →
Citations per field
00.5×3.1×
Patrick Danoy · 1×
Citations per year

Countries citing papers authored by Masato Okada

Since Specialization
Citations

This map shows the geographic impact of Masato Okada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masato Okada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masato Okada more than expected).

Fields of papers citing papers by Masato Okada

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masato Okada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masato Okada. The network helps show where Masato Okada may publish in the future.

Co-authorship network of co-authors of Masato Okada

This figure shows the co-authorship network connecting the top 25 collaborators of Masato Okada. A scholar is included among the top collaborators of Masato Okada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masato Okada. Masato Okada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 7
3 4
4 8
5 25
6 1
7 5
8 1
9 2
10 13
11 7
12 13
13 58
14 5
15 12
16 112
17 65
18 34
19 8
20 21

About Masato Okada

Masato Okada is a scholar working on Rheumatology, Immunology and Aging, having authored 47 papers that have together received 880 indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (17 papers), Systemic Lupus Erythematosus Research (15 papers) and Spondyloarthritis Studies and Treatments (8 papers). The work is most often cited by research in Rheumatology (503 citations), Immunology (457 citations) and Radiology, Nuclear Medicine and Imaging (209 citations). Masato Okada has collaborated with scholars based in Japan, United States and Sweden. Frequent co-authors include Mitsumasa Kishimoto, David Gordon, William Stohl, Damon Bass, Norma Lynn Fox, Morton Scheinberg, C. Kleoudis, Andreas Schwarting, Anne E. Hammer and Andrea Doria. Their work appears in journals such as The Journal of Immunology, PLoS ONE and FEBS Letters.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026